Search Grant Opportunities

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

ID: PAR-22-167 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: May 9, 2022, 12:00 a.m. EDT
The Clinical and Translational Science Award (CTSA) Program Collaborative and Innovative Acceleration Award (CCIA) supports synergistic activities that accelerate the translational research process through collaboration and innovation. This funding opportunity announcement (FOA) invites applications to develop, demonstrate and disseminate innovative solutions to transform the field of translational science by addressing the inefficiencies that are common across diseases and bringing more interventions to all people more quickly through collaborative science among the CTSA Program hubs, NIH Institutes, Centers, Offices (ICOs) and/or external stakeholders.
Posted: Jan. 26, 2022, 12:00 a.m. EST
Posted: Jan. 26, 2022, 12:00 a.m. EST
Show All

Overview

Agency
National Institutes of Health (NIH) [HHS]
Category of Funding
Health
Income Security and Social Services
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
93.121 - Oral Diseases and Disorders Research
93.307 - Minority Health and Health Disparities Research
93.313 - NIH Office of Research on Women's Health
93.350 - National Center for Advancing Translational Sciences
93.846 - Arthritis, Musculoskeletal and Skin Diseases Research
93.859 - Biomedical Research and Research Training
93.865 - Child Health and Human Development Extramural Research
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
Grants.gov
On 5/9/22 the National Institutes of Health posted grant opportunity PAR-22-167 for Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional). The grant will be issued under grant program 93.121 Oral Diseases and Disorders Research.

Timing

Posted Date
May 9, 2022, 12:00 a.m. EDT
Closing Date
Oct. 17, 2024, 12:00 a.m. EDT Past Due
Last Updated
May 9, 2022, 11:07 a.m. EDT
Version
1
Archive Date
Nov. 22, 2024

Eligibility

Eligible Applicants
Public and State controlled institutions of higher education
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Contacts

Contact
National Institutes of Health
Contact Email
oerwebmaster03@od.nih.gov
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information Site
http://grants.nih.gov/grants/guide/pa-files/PAR-22-167.html

Documents

Posted documents for PAR-22-167

Grant Awards

Grants awarded through PAR-22-167

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to PAR-22-167

Experts for Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Recommended subject matter experts available for hire